The informed consent process is important ethically and legally to protect research participants. It ensures participants are fully informed about risks and benefits of a study and can decide voluntarily if they want to participate. The process involves ongoing interactions where information is reiterated to confirm continued informed consent. Principal investigators are ultimately responsible for consent, but they can delegate it to trained study team members. Special care must be taken with vulnerable populations to ensure comprehension. Consents should be presented simply using various tools and time for questions to verify understanding. Documentation confirms consent was obtained properly before any study procedures.
This document discusses the informed consent process. It begins by explaining that informed consent is a process, not just a form. It then provides an IRB submission flow chart and discusses the rules and guidelines that must be followed for informed consent. The document outlines best practices for authoring informed consent forms, including using plain language and avoiding medical jargon. It discusses informed consent considerations for vulnerable populations like children, prisoners, non-English speakers, and cognitively impaired individuals. The document also covers topics like obtaining consent from legally authorized representatives, waiving or altering elements of informed consent, revoking consent, and responsibilities at the end of a study.
The document discusses the ICH GCP guidelines for conducting clinical trials. The key points are:
1) GCP guidelines provide ethical and quality standards for clinical trial conduct to protect subject safety and ensure data credibility.
2) The guidelines establish responsibilities for investigators, sponsors, and ethics committees to follow principles where subject welfare prevails over science and trials must be scientifically sound.
3) The ICH facilitates harmonization across countries/regions to streamline drug development and avoid duplicative trials through consensus guidelines.
The document discusses the purpose and structure of a kick-off meeting or investigator's meeting for a clinical trial. The kick-off meeting is the first meeting between the project team, sponsor, and site staff. It introduces everyone and allows them to discuss their roles. It also reviews the entire study and facilitates communication. The document outlines the typical agenda, attendees, planning considerations, and evaluation process for the kick-off meeting.
Dr. Kaushik Mukhopadhyay's presentation discusses the importance of informed consent in clinical research. It provides an overview of the historical events that led to the formalization of informed consent standards, including the Nuremberg Code, Declaration of Helsinki, and Belmont Report. The presentation outlines the key components of informed consent as defined by international and Indian regulatory guidelines, including providing study information, assessing participant comprehension, and ensuring voluntary participation. It emphasizes that informed consent is a process rather than just a signed form and discusses challenges in obtaining proper consent.
Roles and Responsibilities of sponsor, CRO, and investigator MOHAMMEDSALEEMJM
This slide mainly includes Roles and responsibilities of sponsor CRO and Investigator in Ethical conduct of Clinical Research as per ICH GCP Guidelines
Required mainly for Regulatory affairs students
This document discusses the process of informed consent for clinical research studies. It defines informed consent as a voluntary confirmation by a research subject of their willingness to participate after being informed of all relevant study details. The goal is to provide sufficient information for subjects to make an informed choice about participation. Key aspects of the informed consent process include guidelines from regulatory bodies, ensuring subjects' comprehension and voluntariness, obtaining consent at the right time and place, addressing any questions, and documenting consent with a signed form. The form should include essential elements like the study purpose, risks, benefits, and subjects' rights, as well as additional details like withdrawal criteria and contact information.
Monitoring in clinical trials serves several key purposes: to protect the rights and welfare of human subjects, ensure the accuracy and completeness of trial data, and confirm compliance with regulatory standards and the study protocol. There are various types of monitoring, including central monitoring of data for unusual patterns, risk-based monitoring focusing on higher risk aspects, and on-site monitoring to check participant enrollment and informed consent, study conduct, drug accountability, and accuracy of source data documentation. Routine monitoring visits evaluate study progress, resources, laboratory facilities, investigational products, compliance with the protocol and regulations, case report forms, source data verification, adverse events documentation, and regulatory files.
This document discusses the informed consent process. It begins by explaining that informed consent is a process, not just a form. It then provides an IRB submission flow chart and discusses the rules and guidelines that must be followed for informed consent. The document outlines best practices for authoring informed consent forms, including using plain language and avoiding medical jargon. It discusses informed consent considerations for vulnerable populations like children, prisoners, non-English speakers, and cognitively impaired individuals. The document also covers topics like obtaining consent from legally authorized representatives, waiving or altering elements of informed consent, revoking consent, and responsibilities at the end of a study.
The document discusses the ICH GCP guidelines for conducting clinical trials. The key points are:
1) GCP guidelines provide ethical and quality standards for clinical trial conduct to protect subject safety and ensure data credibility.
2) The guidelines establish responsibilities for investigators, sponsors, and ethics committees to follow principles where subject welfare prevails over science and trials must be scientifically sound.
3) The ICH facilitates harmonization across countries/regions to streamline drug development and avoid duplicative trials through consensus guidelines.
The document discusses the purpose and structure of a kick-off meeting or investigator's meeting for a clinical trial. The kick-off meeting is the first meeting between the project team, sponsor, and site staff. It introduces everyone and allows them to discuss their roles. It also reviews the entire study and facilitates communication. The document outlines the typical agenda, attendees, planning considerations, and evaluation process for the kick-off meeting.
Dr. Kaushik Mukhopadhyay's presentation discusses the importance of informed consent in clinical research. It provides an overview of the historical events that led to the formalization of informed consent standards, including the Nuremberg Code, Declaration of Helsinki, and Belmont Report. The presentation outlines the key components of informed consent as defined by international and Indian regulatory guidelines, including providing study information, assessing participant comprehension, and ensuring voluntary participation. It emphasizes that informed consent is a process rather than just a signed form and discusses challenges in obtaining proper consent.
Roles and Responsibilities of sponsor, CRO, and investigator MOHAMMEDSALEEMJM
This slide mainly includes Roles and responsibilities of sponsor CRO and Investigator in Ethical conduct of Clinical Research as per ICH GCP Guidelines
Required mainly for Regulatory affairs students
This document discusses the process of informed consent for clinical research studies. It defines informed consent as a voluntary confirmation by a research subject of their willingness to participate after being informed of all relevant study details. The goal is to provide sufficient information for subjects to make an informed choice about participation. Key aspects of the informed consent process include guidelines from regulatory bodies, ensuring subjects' comprehension and voluntariness, obtaining consent at the right time and place, addressing any questions, and documenting consent with a signed form. The form should include essential elements like the study purpose, risks, benefits, and subjects' rights, as well as additional details like withdrawal criteria and contact information.
Monitoring in clinical trials serves several key purposes: to protect the rights and welfare of human subjects, ensure the accuracy and completeness of trial data, and confirm compliance with regulatory standards and the study protocol. There are various types of monitoring, including central monitoring of data for unusual patterns, risk-based monitoring focusing on higher risk aspects, and on-site monitoring to check participant enrollment and informed consent, study conduct, drug accountability, and accuracy of source data documentation. Routine monitoring visits evaluate study progress, resources, laboratory facilities, investigational products, compliance with the protocol and regulations, case report forms, source data verification, adverse events documentation, and regulatory files.
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Dr B Naga Raju
Presentation on Roles and Responsibilities of sponsor in conducting clinical trials as per GCP-ICH for pursuing a subject in the course of PharmD programme under RGUHS
Clinical trials have a long history dating back to Avicenna in the 11th century who established principles for testing drug effectiveness. Modern clinical trials involve extensive pre-clinical testing followed by 4 phases of human trials. Phase I trials in healthy volunteers establish safety. Phase II trials in patients provide preliminary efficacy and safety data. Phase III trials involve thousands of patients to confirm efficacy and monitor side effects. Phase IV occurs after approval to further monitor long-term safety. Randomization, blinding, and use of control groups aim to reduce bias in trial design and interpretation of results.
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSjyothibhat21
This presentation highlights the regulations on Ethical requirements for conducting clinical research in India. This is the guiding regulation for the Ethics Committees in India.
The viewers are requested to give their feedback on the utility of the presentation.
The document discusses factors to consider when selecting clinical trial sites and investigators. Key criteria for site selection include the experience and qualifications of staff, availability of suitable patients, and ability to perform required assessments. Important considerations for investigator selection are their education, training, experience recruiting patients, and ability to properly conduct the trial within the required timelines. The selection process involves sponsors asking CROs to evaluate potential sites and investigators through feasibility interviews and assessments of qualifications.
The document discusses the history and guidelines of informed consent. It covers the basic principles of autonomy, beneficence, and justice. The key elements of informed consent include description of the study, risks/benefits, voluntary participation, and signature of consent. Special protections are in place for vulnerable groups like children, prisoners, pregnant women. The investigator is responsible for ensuring subjects understand research aspects before participation.
This document discusses audits and inspections in clinical trials. It defines an audit as a systematic examination of trial activities and documents to determine compliance, while an inspection involves a regulatory review of documents, facilities, and resources related to a trial. The key differences between audits and inspections are that audits are conducted internally by sponsors or CROs, while inspections are done by regulatory authorities. Routine audits ensure compliance, while for-cause audits investigate non-compliance issues. Audits and inspections evaluate areas like personnel, trial conduct, documentation, drug accountability, and computer systems. Proper preparation and responding to document requests within time limits are important for audits and inspections.
The document outlines the responsibilities of an investigator in clinical trials. An investigator is responsible for leading the clinical trial team and ensuring compliance with regulations. Key responsibilities include obtaining necessary approvals, ensuring safety of trial subjects, obtaining informed consent, accurately collecting and reporting data, and protecting subjects' rights and well-being. Maintaining high ethical standards in clinical trials is important to generate credible results and provide assurance to the public.
An informed consent form is a document that is provided to prospective participants in a research study. It is a crucial component of the informed consent process and serves to ensure that participants are fully informed about the study and its potential risks and benefits before they decide to participate. Here are the key elements typically included in an informed consent form
A presentation on INFORMED CONSENT FORM which is easy to understand and easy to explain and in very understandable language. Do give it a heart if you like this presentation and do give your valuable comments on it. I will be reading them all. Do contact me if you want some other presentation related to pharmaceutical science.
Before the enrollment of a patient in a clinical trial and beginning of any trial-related procedures, an informed consent is obtained from the potential participants. This informed consent form (ICF) provides the participants with the information related to the clinical trial. TSDP provides regulatory medical writing training on preparation of ICF.
Clinical trials are conducted to test new drugs, treatments or medical devices in humans to assess their safety and efficacy. There are four main phases of clinical trials:
Phase I trials involve small groups of people to determine basic safety and dosing requirements. Phase II trials expand the testing to more people to determine efficacy and further evaluate safety. Phase III trials involve large groups of people to confirm effectiveness, monitor side effects, compare to commonly used treatments and collect information to allow safe use of the intervention. Phase IV trials occur after the intervention has been marketed to gather information on effects in various populations and any long-term side effects.
The document outlines ethical guidelines for biomedical research on human subjects established by the Indian Council of Medical Research (ICMR). It discusses ICMR's role in regulating medical research in India and establishes general principles for ethical research involving human participants, including principles of voluntary and informed consent, privacy/confidentiality, and minimizing risks. It also covers specific ethical considerations for certain types of clinical trials and establishes procedures for ethical review of research by institutional ethics committees.
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxE Poovarasan
This document outlines the roles and responsibilities of key personnel in clinical trials, including the investigator, study coordinator, and other members of the research team. It describes that the investigator is responsible for conducting the trial according to the protocol and protecting participants. The study coordinator works under the investigator and is responsible for coordinating study visits, obtaining consent, and ensuring compliance. Other duties of the research team include reporting adverse events, maintaining proper records, and following Good Clinical Practice standards.
Lets, just get to know more about safety reporting in clinical trails with some terminologies, reporting requirements of ADR, compensations involved and finally the role of ethics committee in it,
The sponsor is responsible for initiating, managing, and financing clinical trials. This includes selecting investigators and sites, defining responsibilities, submitting documents for regulatory approval, monitoring safety and progress, ensuring proper labeling and storage of investigational products, auditing sites for compliance, and preparing and submitting clinical trial reports to regulatory authorities. The sponsor may delegate trial-related duties to third parties like CROs but retains ultimate responsibility for the trial.
Amendments in Schedule Y in 2013,2014 inserted three new rules, new appendix XII: compensation in case of injury or death during clinical trial, amendments in ICD and appendix V inform consent form format.
This document provides an overview of clinical research and clinical trials. It defines clinical research and clinical trials, discusses the importance of research. It describes the different types and phases of clinical trials, from phase 0 to phase IV. It outlines the key players involved in clinical trials and provides an overview of the clinical trial process from study design to statistical analysis and reporting.
- Informed consent is a process that involves fully informing potential research participants of the risks and benefits of a study, ensuring they understand this information, and obtaining their voluntary agreement to participate.
- Historical abuses of informed consent like the Nazi prisoner experiments led to modern guidelines like the Nuremberg Code to protect research participants.
- Current informed consent standards outlined in documents like the Declaration of Helsinki and ICMR Guidelines in India require voluntary participation, complete disclosure of study details, participant understanding, and formal authorization from participants.
This document reviews Good Clinical Practice (GCP) guidelines. It aims to study GCP principles and their application. The document outlines the objectives, contents, and introduction to GCP. It describes 14 GCP principles regarding ethical conduct of clinical trials, including protocol development, risk identification, benefit-risk assessment, review by ethics committees, informed consent, qualifications of investigators and staff, record keeping, confidentiality, manufacturing standards, and quality systems. The document provides examples of how each principle is applied in clinical research. It concludes with a bibliography on GCP guidelines and resources.
The document discusses case report forms (CRFs), which are used in clinical trials to record patient data. It defines CRFs and explains that they contain all protocol-required information including adverse events. The goals of CRFs are to collect verifiable data according to Good Clinical Practice standards. CRFs can be paper-based or electronic. Well-designed CRFs are structured and formatted consistently to facilitate accurate data collection while avoiding duplication. CRFs provide essential standardized data that is analyzed to advance medical research.
This document discusses informed consent and provides guidance on obtaining informed consent for research studies. It defines informed consent as a process of communicating information about a research study to a potential subject, including risks and benefits, to allow them to make an informed decision about participating. The key elements that must be included in an informed consent form and discussed with subjects are outlined. Guidelines are provided around assessing subject understanding, consenting special populations, documenting the consent process, and ensuring consent forms are written at an appropriate reading level. Maintaining regulatory compliance with informed consent requirements is emphasized as it is important for subject protection.
Chicagoland Occupational Therapy Fieldwork Site StudyBhumi Bhatt
This document summarizes feedback from OT students and practitioners regarding fieldwork sites and programs in the Chicagoland area. It provides ratings of fieldwork experiences across different settings and identifies strengths and opportunities for different sites. Recommendations are given for OT programs to better prepare students and for students to have a successful fieldwork, including being respectful of supervisors, keeping an open mind, communicating needs, and asking questions. Acute care experiences were highly rated while behavioral health sites could be improved. Programs should focus more on hands-on learning and interventions.
Roles and Responsibilities of sponsor in conducting clinical trials as per GC...Dr B Naga Raju
Presentation on Roles and Responsibilities of sponsor in conducting clinical trials as per GCP-ICH for pursuing a subject in the course of PharmD programme under RGUHS
Clinical trials have a long history dating back to Avicenna in the 11th century who established principles for testing drug effectiveness. Modern clinical trials involve extensive pre-clinical testing followed by 4 phases of human trials. Phase I trials in healthy volunteers establish safety. Phase II trials in patients provide preliminary efficacy and safety data. Phase III trials involve thousands of patients to confirm efficacy and monitor side effects. Phase IV occurs after approval to further monitor long-term safety. Randomization, blinding, and use of control groups aim to reduce bias in trial design and interpretation of results.
ETHICAL GUIDELINES FOR BIOMEDICAL RESEARCH ON HUMAN PARTICIPANTSjyothibhat21
This presentation highlights the regulations on Ethical requirements for conducting clinical research in India. This is the guiding regulation for the Ethics Committees in India.
The viewers are requested to give their feedback on the utility of the presentation.
The document discusses factors to consider when selecting clinical trial sites and investigators. Key criteria for site selection include the experience and qualifications of staff, availability of suitable patients, and ability to perform required assessments. Important considerations for investigator selection are their education, training, experience recruiting patients, and ability to properly conduct the trial within the required timelines. The selection process involves sponsors asking CROs to evaluate potential sites and investigators through feasibility interviews and assessments of qualifications.
The document discusses the history and guidelines of informed consent. It covers the basic principles of autonomy, beneficence, and justice. The key elements of informed consent include description of the study, risks/benefits, voluntary participation, and signature of consent. Special protections are in place for vulnerable groups like children, prisoners, pregnant women. The investigator is responsible for ensuring subjects understand research aspects before participation.
This document discusses audits and inspections in clinical trials. It defines an audit as a systematic examination of trial activities and documents to determine compliance, while an inspection involves a regulatory review of documents, facilities, and resources related to a trial. The key differences between audits and inspections are that audits are conducted internally by sponsors or CROs, while inspections are done by regulatory authorities. Routine audits ensure compliance, while for-cause audits investigate non-compliance issues. Audits and inspections evaluate areas like personnel, trial conduct, documentation, drug accountability, and computer systems. Proper preparation and responding to document requests within time limits are important for audits and inspections.
The document outlines the responsibilities of an investigator in clinical trials. An investigator is responsible for leading the clinical trial team and ensuring compliance with regulations. Key responsibilities include obtaining necessary approvals, ensuring safety of trial subjects, obtaining informed consent, accurately collecting and reporting data, and protecting subjects' rights and well-being. Maintaining high ethical standards in clinical trials is important to generate credible results and provide assurance to the public.
An informed consent form is a document that is provided to prospective participants in a research study. It is a crucial component of the informed consent process and serves to ensure that participants are fully informed about the study and its potential risks and benefits before they decide to participate. Here are the key elements typically included in an informed consent form
A presentation on INFORMED CONSENT FORM which is easy to understand and easy to explain and in very understandable language. Do give it a heart if you like this presentation and do give your valuable comments on it. I will be reading them all. Do contact me if you want some other presentation related to pharmaceutical science.
Before the enrollment of a patient in a clinical trial and beginning of any trial-related procedures, an informed consent is obtained from the potential participants. This informed consent form (ICF) provides the participants with the information related to the clinical trial. TSDP provides regulatory medical writing training on preparation of ICF.
Clinical trials are conducted to test new drugs, treatments or medical devices in humans to assess their safety and efficacy. There are four main phases of clinical trials:
Phase I trials involve small groups of people to determine basic safety and dosing requirements. Phase II trials expand the testing to more people to determine efficacy and further evaluate safety. Phase III trials involve large groups of people to confirm effectiveness, monitor side effects, compare to commonly used treatments and collect information to allow safe use of the intervention. Phase IV trials occur after the intervention has been marketed to gather information on effects in various populations and any long-term side effects.
The document outlines ethical guidelines for biomedical research on human subjects established by the Indian Council of Medical Research (ICMR). It discusses ICMR's role in regulating medical research in India and establishes general principles for ethical research involving human participants, including principles of voluntary and informed consent, privacy/confidentiality, and minimizing risks. It also covers specific ethical considerations for certain types of clinical trials and establishes procedures for ethical review of research by institutional ethics committees.
ROLES AND RESPONSIBLITIES OF CLINICAL TRIAL PERSONNEL-INVESTIGATOR.pptxE Poovarasan
This document outlines the roles and responsibilities of key personnel in clinical trials, including the investigator, study coordinator, and other members of the research team. It describes that the investigator is responsible for conducting the trial according to the protocol and protecting participants. The study coordinator works under the investigator and is responsible for coordinating study visits, obtaining consent, and ensuring compliance. Other duties of the research team include reporting adverse events, maintaining proper records, and following Good Clinical Practice standards.
Lets, just get to know more about safety reporting in clinical trails with some terminologies, reporting requirements of ADR, compensations involved and finally the role of ethics committee in it,
The sponsor is responsible for initiating, managing, and financing clinical trials. This includes selecting investigators and sites, defining responsibilities, submitting documents for regulatory approval, monitoring safety and progress, ensuring proper labeling and storage of investigational products, auditing sites for compliance, and preparing and submitting clinical trial reports to regulatory authorities. The sponsor may delegate trial-related duties to third parties like CROs but retains ultimate responsibility for the trial.
Amendments in Schedule Y in 2013,2014 inserted three new rules, new appendix XII: compensation in case of injury or death during clinical trial, amendments in ICD and appendix V inform consent form format.
This document provides an overview of clinical research and clinical trials. It defines clinical research and clinical trials, discusses the importance of research. It describes the different types and phases of clinical trials, from phase 0 to phase IV. It outlines the key players involved in clinical trials and provides an overview of the clinical trial process from study design to statistical analysis and reporting.
- Informed consent is a process that involves fully informing potential research participants of the risks and benefits of a study, ensuring they understand this information, and obtaining their voluntary agreement to participate.
- Historical abuses of informed consent like the Nazi prisoner experiments led to modern guidelines like the Nuremberg Code to protect research participants.
- Current informed consent standards outlined in documents like the Declaration of Helsinki and ICMR Guidelines in India require voluntary participation, complete disclosure of study details, participant understanding, and formal authorization from participants.
This document reviews Good Clinical Practice (GCP) guidelines. It aims to study GCP principles and their application. The document outlines the objectives, contents, and introduction to GCP. It describes 14 GCP principles regarding ethical conduct of clinical trials, including protocol development, risk identification, benefit-risk assessment, review by ethics committees, informed consent, qualifications of investigators and staff, record keeping, confidentiality, manufacturing standards, and quality systems. The document provides examples of how each principle is applied in clinical research. It concludes with a bibliography on GCP guidelines and resources.
The document discusses case report forms (CRFs), which are used in clinical trials to record patient data. It defines CRFs and explains that they contain all protocol-required information including adverse events. The goals of CRFs are to collect verifiable data according to Good Clinical Practice standards. CRFs can be paper-based or electronic. Well-designed CRFs are structured and formatted consistently to facilitate accurate data collection while avoiding duplication. CRFs provide essential standardized data that is analyzed to advance medical research.
This document discusses informed consent and provides guidance on obtaining informed consent for research studies. It defines informed consent as a process of communicating information about a research study to a potential subject, including risks and benefits, to allow them to make an informed decision about participating. The key elements that must be included in an informed consent form and discussed with subjects are outlined. Guidelines are provided around assessing subject understanding, consenting special populations, documenting the consent process, and ensuring consent forms are written at an appropriate reading level. Maintaining regulatory compliance with informed consent requirements is emphasized as it is important for subject protection.
Chicagoland Occupational Therapy Fieldwork Site StudyBhumi Bhatt
This document summarizes feedback from OT students and practitioners regarding fieldwork sites and programs in the Chicagoland area. It provides ratings of fieldwork experiences across different settings and identifies strengths and opportunities for different sites. Recommendations are given for OT programs to better prepare students and for students to have a successful fieldwork, including being respectful of supervisors, keeping an open mind, communicating needs, and asking questions. Acute care experiences were highly rated while behavioral health sites could be improved. Programs should focus more on hands-on learning and interventions.
The document discusses patient education, including its goals of promoting health, changing behaviors, and improving compliance. It covers assessing patient needs, learning styles, health literacy, and readiness to learn. It also discusses planning education by creating goals and objectives, implementing education using various aids, evaluating comprehension, improving adherence, and involving support systems like families and groups. The overall purpose is to provide patients with the knowledge and skills to better manage their health.
This document discusses various ethical issues related to research involving human subjects. It addresses the need for informed consent, minimizing risks and assessing participant understanding. Key points covered include obtaining consent, withdrawal procedures, deception/concealment, assessing risks, and maintaining participant confidentiality and autonomy. Overall, the document emphasizes that research ethics are important to consider for any study involving human participants.
From the event "Specimen Science: Ethics and Policy Implications," held at Harvard Law School on November 16, 2015.
This event was a collaboration between The Center for Child Health and Policy at Case Western Reserve University and University Hospitals Rainbow Babies & Children’s Hospital; the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; the Multi-Regional Clinical Trials Center of Harvard and Brigham and Women's Hospital; and Harvard Catalyst | The Harvard Clinical and Translational Science Center. It was supported by funding from the National Human Genome Research Institute and the Oswald DeN. Cammann Fund at Harvard University.
For more information, visit our website at http://petrieflom.law.harvard.edu/events/details/specimen-science-ethics-and-policy
This is about Informed Consent, in Bio-Ethics, this must be taken from participants before doing any Research, involving Human Participants. And I obtained this information from ICMR's Publication of 2017 about Bio-Ethics.
This document outlines the key elements of obtaining informed consent, including what informed consent is, the ethical basis for requiring it, the consent process, what is needed for valid informed consent, elements that must be included, and special situations like children and waivers. It discusses how informed consent applies the ethical principle of respect for persons and facilitates trust in research. The consent process and what must be included in the consent form are described. Challenges like illiteracy, culture, child assent, and stored samples are also addressed.
This document discusses research ethics and provides definitions and outlines of key topics in research ethics. It defines research ethics as the application of moral principles guiding research from inception to publication. It identifies the importance of ethics in protecting participants and building public support. The key principles of ethics discussed are consent, harm, privacy, and deception. Informed consent and minimizing risk of harm to participants are emphasized.
The document provides information on patient and family education. It defines patient teaching as preparing patients and families to care for themselves during hospitalization and after discharge. The purposes of education are to identify learning needs, facilitate understanding of health status and care options, and promote healthy lifestyles. Education occurs through interactions with providers and is coordinated. Barriers and readiness to learn are assessed. Education should be ongoing, interactive, and include family members.
Basic principles, interview style, various components and their significance, how to take history of present illness, past history,family and personal history, substance history, premorbid personality
The document provides information about the process of obtaining informed consent from participants in clinical trials and research. It discusses key elements of informed consent including understanding the purpose and risks of the research, participation being voluntary, and procedures to ensure comprehension. The summary is as follows:
1. The document outlines the important elements of informed consent such as understanding the nature, risks, and benefits of the research as well as the voluntary nature of participation.
2. It discusses the informed consent process including providing information verbally and in writing, allowing time for questions, and obtaining signatures. Special considerations are given for vulnerable populations.
3. Electronic methods of consent are also discussed as an alternative to traditional paper-based informed consent forms.
This document provides guidance on developing comprehensive and legally compliant consent documents for research. It reviews the key elements that must be included in a consent form according to federal regulations, such as risks, benefits, confidentiality, voluntary participation, and contact information. The document also discusses additional consent requirements for clinical trials and situations where waivers of documentation or consent may be permitted. Researchers are advised to write consent forms at a 6th-8th grade reading level using clear and simple language.
Lecture 7-research ethics and engaging culture.pptxXiaolanDeng1
This document outlines the key aspects of research ethics and procedures for protecting study participants. It discusses definitions of ethics and human research, why research ethics are important, and the ethical principles of human dignity, consent, protecting vulnerable groups, privacy/confidentiality, balancing risks and benefits, and justice/inclusiveness. It describes procedures like risk-benefit assessments and issues around participants. It also focuses on the ethical treatment of vulnerable groups like children, disabled people, the severely ill, terminally ill, and institutionalized individuals.
Day four qualitative workshop presentation Dagu Project
I apologize for interrupting, but I noticed the facilitator asked an open-ended question and the respondent provided a short yes/no answer without elaboration. It may be helpful for the facilitator to use prompts like "Can you tell me more about that?" or reflections like "It seems like there may be more to the story" to encourage the respondent to expand on their response. Open-ended questions followed by active listening and occasional prompts tend to yield richer qualitative data.
Stuart Lane takes saying sorry seriously. Seriously seriously. To the extend he's nearly finished his PhD on it. Listen to this fantastic talk, watch the slides and add comments your comments on www.intensivecarenetwork.com.
How to Bust Clinical Trial Myths and Increase Participation - mdgroupmdgroup
In order for the public to benefit from ground-breaking medical research, well-attended clinical trials are vital. What holds potential participants back from participating in trials?
This document summarizes discussions from a curriculum development workshop for the Northern Territory Medical Program. It outlines activities conducted at the workshop to contextualize the medical school curriculum for the NT. The activities focused on identifying graduate outcomes, curriculum content and sequencing, learning challenges, and maximizing learning opportunities in the NT context. The goal was to develop a fit-for-purpose, outcomes-based curriculum aligned with NT health needs and delivered using a variety of educational strategies.
Informed Consent in Critical Care ResearchSteve Mathieu
This document discusses key aspects of obtaining informed consent in critical care research. It emphasizes that everyone involved in the consent process should be fully informed about the study and understand the participant's circumstances. Consent must be obtained prior to any study procedures and researchers must be trained to perform this role. When participants lack capacity, a legal representative may provide consent according to law. Special considerations are given for vulnerable populations like prisoners. The document stresses avoiding therapeutic misconception and fully addressing participant's questions and understanding of risks.
Difficult Conversations: Bridging the Communication Gap with Your OncologistMelissa Sakow
Lidia Schapira, MD, Director of the Cancer Survivorship Program at Stanford University, shares her expertise to help you get the most out of your communication with your oncologist. Learn strategies to optimize your meetings with your health care team.
Difficult Conversations: Bridging the Communication Gap with your Oncologistbkling
Lidia Schapira, MD, Director of the Cancer Survivorship Program at Stanford University, shares her expertise to help you get the most out of your communication with your oncologist. Learn strategies to optimize your meetings with your health care team.
End-tidal carbon dioxide (ETCO2) is the level of carbon dioxide that is released at the end of an exhaled breath. ETCO2 levels reflect the adequacy with which carbon dioxide (CO2) is carried in the blood back to the lungs and exhaled.
Non-invasive methods for ETCO2 measurement include capnometry and capnography. Capnometry provides a numerical value for ETCO2. In contrast, capnography delivers a more comprehensive measurement that is displayed in both graphical (waveform) and numerical form.
Sidestream devices can monitor both intubated and non-intubated patients, while mainstream devices are most often limited to intubated patients.
The Importance of Black Women Understanding the Chemicals in Their Personal C...bkling
Certain chemicals, such as phthalates and parabens, can disrupt the body's hormones and have significant effects on health. According to data, hormone-related health issues such as uterine fibroids, infertility, early puberty and more aggressive forms of breast and endometrial cancers disproportionately affect Black women. Our guest speaker, Jasmine A. McDonald, PhD, an Assistant Professor in the Department of Epidemiology at Columbia University in New York City, discusses the scientific reasons why Black women should pay attention to specific chemicals in their personal care products, like hair care, and ways to minimize their exposure.
This particular slides consist of- what is Pneumothorax,what are it's causes and it's effect on body, risk factors, symptoms,complications, diagnosis and role of physiotherapy in it.
This slide is very helpful for physiotherapy students and also for other medical and healthcare students.
Here is a summary of Pneumothorax:
Pneumothorax, also known as a collapsed lung, is a condition that occurs when air leaks into the space between the lung and chest wall. This air buildup puts pressure on the lung, preventing it from expanding fully when you breathe. A pneumothorax can cause a complete or partial collapse of the lung.
Fit to Fly PCR Covid Testing at our Clinic Near YouNX Healthcare
A Fit-to-Fly PCR Test is a crucial service for travelers needing to meet the entry requirements of various countries or airlines. This test involves a polymerase chain reaction (PCR) test for COVID-19, which is considered the gold standard for detecting active infections. At our travel clinic in Leeds, we offer fast and reliable Fit to Fly PCR testing, providing you with an official certificate verifying your negative COVID-19 status. Our process is designed for convenience and accuracy, with quick turnaround times to ensure you receive your results and certificate in time for your departure. Trust our professional and experienced medical team to help you travel safely and compliantly, giving you peace of mind for your journey.www.nxhealthcare.co.uk
Joker Wigs has been a one-stop-shop for hair products for over 26 years. We provide high-quality hair wigs, hair extensions, hair toppers, hair patch, and more for both men and women.
English Drug and Alcohol Commissioners June 2024.pptxMatSouthwell1
Presentation made by Mat Southwell to the Harm Reduction Working Group of the English Drug and Alcohol Commissioners. Discuss stimulants, OAMT, NSP coverage and community-led approach to DCRs. Focussing on active drug user perspectives and interests
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTblessyjannu21
Prepared by Prof. BLESSY THOMAS, VICE PRINCIPAL, FNCON, SPN.
Emphysema is a disease condition of respiratory system.
Emphysema is an abnormal permanent enlargement of the air spaces distal to terminal bronchioles, accompanied by destruction of their walls and without obvious fibrosis.
Emphysema of lung is defined as hyper inflation of the lung ais spaces due to obstruction of non respiratory bronchioles as due to loss of elasticity of alveoli.
It is a type of chronic obstructive
pulmonary disease.
It is a progressive disease of lungs.
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVedanta A
Air Ambulance Services In Rewa works in close coordination with ground-based emergency services, including local Emergency Medical Services, fire departments, and law enforcement agencies.
More@: https://tinyurl.com/2shrryhx
More@: https://tinyurl.com/5n8h3wp8
The facial nerve, also known as cranial nerve VII, is one of the 12 cranial nerves originating from the brain. It's a mixed nerve, meaning it contains both sensory and motor fibres, and it plays a crucial role in controlling various facial muscles, as well as conveying sensory information from the taste buds on the anterior two-thirds of the tongue.
Sectional dentures for microstomia patients.pptxSatvikaPrasad
Microstomia, characterized by an abnormally small oral aperture, presents significant challenges in prosthodontic treatment, including limited access for examination, difficulties in impression making, and challenges with prosthesis insertion and removal. To manage these issues, customized impression techniques using sectional trays and elastomeric materials are employed. Prostheses may be designed in segments or with flexible materials to facilitate handling. Minimally invasive procedures and the use of digital technologies can enhance patient comfort. Education and training for patients on prosthesis care and maintenance are crucial for compliance. Regular follow-up and a multidisciplinary approach, involving collaboration with other specialists, ensure comprehensive care and improved quality of life for microstomia patients.
Emotional and Behavioural Problems in Children - Counselling and Family Thera...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Emotional and Behavioural Problems in Children - Counselling and Family Thera...
Informed consent process
1. Informed Consent Process
Kathleen O’Malley RN, BSN, CCRP
Manager of Education and Training
Jefferson Clinical Research Institute
kathleen.omalley@jefferson.edu
2. Why is it so important?
Why is it referred to as a process?
Who, what, where, when, why and
how of Informed Consent process?
What are your responsibilities?
2
3. “The single biggest problem in
communication is the illusion that it
has taken place.”
George Bernard Shaw
3
4. Why is it informed consent so important?
• Ethical requirement and the LAW!
• Protects the rights, safety and wellbeing
of subjects
• Ensures the subject is fully and accurately
informed
• Comprehends the information
• Decision is voluntary
4
5. Why is it referred to as a process?
• Ongoing interaction between the subject and
research personnel
• Begins with the first contact and exchange of
information
• Continues beyond study termination
Each contact is an opportunity to reiterate
information and ensure that participation
continues to be fully informed and
voluntary
5
6. The informed consent document is a
teaching tool:
• Describes:
• requirements of the protocol
• responsibilities of the subject
• risks/benefits of participation
• Documentation of consent is only the first step
• Documents voluntary and informed consent,
prior to any study procedures
6
7. Who should present and obtain the
informed consent?
• Principal Investigator
• Study personnel designated and trained by the PI*
• Sub-investigator, CRC, key personnel
• Appropriately qualified (CITI trained)
• Appropriately trained and intimately familiar
with protocol
• Adequate medical knowledge and understanding
of potential adverse effects
• Ability to communicate effectively
WHO:
7
8. Delegation of Authority (DOA) (Log):
The assignment of responsibility to another person to
carry out specific activities
• Authority may be delegated, but ultimate
responsibility still rests with PI
The Investigator has the authority to delegate any study-
related task and responsibility to any member of the
study team who has been properly trained to carry out
the designated function.
TJU Policy: GA 125, 3.3.1
WHO:
8
9. Who should present and obtain the
informed consent?
The ultimate responsibility for ensuring informed
consent is obtained, and that the consent interview
is conducted in such a way that all questions and
concerns are answered, rests with the PI.
If the consent interview is conducted by key
personnel other than the PI, the PI or Co-I must be
reachable by phone, if the subject has questions that
cannot be answered by the person conducting the
interview.
TJU OHR Policy IC 701, 4.4
WHO:
9
10. Primary physician vs. Study physician?
• If PI is also the primary physician:
• Roles may become blurred
• Imbalance of power between patient and doctor
• Patient may feel they don’t want to disappoint
Doctor
• Patient may confuse research with clinical care
• Recruiting a patient is not the same
as recruiting a subject
WHO:
10
11. Therapeutic Misconception:
The belief held by a research subject that the purpose of
the research is to provide therapeutic benefit
Therapeutic Misestimation:
When subjects overestimate the benefits that a study
can provide them or when they underestimate the
potential risks associated with a study.
Both are detrimental to a subject’s understanding of a
study, which is crucial for an autonomous decision
11
12. Who can give informed consent?
• The subject or the subject’s legally authorized
representative (LAR)
• Adults (over the age of 18) or “the person has married,
has been pregnant, or has been graduated from high
school may give effective consent and the consent of
no other person shall be necessary”
** see TJU OHR Policy IC 704, 4.0 for applicable
definitions
http://www.jefferson.edu/content/dam/tju/human_research/irb/documents/PolicyandProcedure
sManual/20151201%20DO%20NOT%20MODIFY%20Policy%20and%20Procedure%20Manual%20COMPLETE
%20CLEAN%20fixed.pdf
WHO:
12
13. Special Circumstances
(AKA: Vulnerable Populations):
• Children (parents give consent – child gives assent)
• Persons illiterate in English (understands, but does not
read)
• Persons that do not understand or speak English
• Hearing or vision impaired
• Ask about glasses +/or hearing aids!
• Individuals physically unable to sign
• Prisoners, Students
• Cognitively impaired, mental disorders
• Economically or Educationally disadvantaged
WHO:
13
14. Special Circumstances:
PLANNING = SUCCESS!
• Consider safety beyond the time of consent
• Need adequate time!
• Low literacy can prevent understanding
• See TJU OHR Policies and Procedures for guidance
14
15. Non-English speakers:
• Appropriately translated consent forms and/or foreign
language versions of short form consent documents
must be approved by the IRB prior to enrolling subjects
• CAUTION- Family members as translators
• Inadequate understanding of medical terms and
research
• May not translate verbatim
• Not unbiased
• May not share all information (both directions)
• May be culturally/socially inappropriate
WHO:
15
16. Non-English speakers:
**Note: If a translator and/or translated consent
is used, a “translator should also be available
during the full course of the non-English
speaker’s participation in the study, so that the
subject can always communicate reliably with
the research team, which is a right of any
research subject.”
TJU OHR Policy IC 705, 4.5
WHO:
16
17. The informed consent document is a
teaching tool:
• Must include comprehensive study information
• In language that is understandable to subject
• Contain all elements required by applicable
regulations
With increasingly complex studies, it is a challenge.
Unfortunately, most are very long, poorly written
and organized, and complicated.
WHAT:
17
19. Informed consent as a teaching tool
• As simple and short as possible!
• Avoid medical terms/technical jargon = Lay
language
• Short sentences
• Large font, organized layout
• Balance text with white space
• 5th-7th grade reading level (10-12yrs old)
• Use supplemental strategies (visual aids,
pamphlets, video/computer presentations)
WHAT:
19
20. Best Practices:
• Comfortable setting
• Private
• Neutral
• With or without family/friends
• (Adequate time!)
*Need to be flexible and adaptable within the
confines of the clinical setting. Try to optimize
above.
WHERE:
20
22. Where should consents be stored?
Signed consents:
-Original: study record
-Copies: Subject, eMR
Original, unsigned, IRB approved consents:
-Regulatory binder
CAUTION: copies should be printed on an as
needed basis ONLY!
• One of the most common mistakes is using the
wrong version.
WHERE:
22
23. Preparing to discuss informed
consent document:
• Subject understand English?
• Level of education/comprehension ability?
• **Vulnerable subject/special circumstances?
• Maximize location and availability of time?
• Involvement of others (parent, LAR, family, etc.)?
In some instances, provide a copy of consent in advance
of first meeting
• must be part of IRB approved plan
WHEN:
23
24. BEFORE:
-Any study procedures are performed!!
AFTER:
-IRB approval
-Review of consent form
-Questions, concerns answered
-Discussion with family, friends, other
providers
-Adequate time for consideration
WHEN:
24
25.
26. When is informed consent not needed?
• If you have obtained an IRB approved waiver of
informed consent
TJU OHR Policy IC 706
When do you need to re-consent a
subject?
• If new information is learned, during the course of
the study that may affect the subject’s willingness
to participate
• New information that affects risks or benefits*
• *IRB will determine if current subjects must re-
consented
WHEN:
26
27. Remember:
Every subject contact is an
opportunity to reiterate information
and ensure that participation
continues to be fully informed and
voluntary.
WHEN:
27
28. Presenting the informed consent-Best
Practices:
• Know your target audience – adapt appropriately
• Use tools: visual aids, videos, tablets,
demonstrations
• Practice presenting the consent before use
• Repetition of key words, points, phrases
• Ask subject to repeat words, points phrases
• Speak clearly and slowly
HOW:
28
29. Presenting the informed consent-Best
Practices:
• Send consent form in advance
• Place teach back moments throughout, to assess
comprehension as you move forward
• Consider a “post-test”
• Keep it conversational
• Watch your subject
• Adequate TIME!
Provide non-judgmental, safe and welcoming
environment
HOW:
29
30. How to assess comprehension:
Teach-back, or “Tell me in your own words”:
• How would you describe this study to your
friends/family?
• What will happen to you in this study?
• What will you gain by participating?
• What are the potential risks/adverse effects that
may happen?
• What are the alternatives treatments to being in
the study?
HOW:
30
31. Avoid undue influence/coercion:
Coercion: an overt or implicit threat of harm is presented
to obtain compliance
Ex. PI tells prospective subject that s/he will lose access
to needed health services if they don’t participate
Undue influence: excessive or inappropriate reward
offered to obtain compliance
Ex. PI offers his/her students extra credit if they
participate in a research study (and it is the only way
they can earn the credit)
HOW:
Lui and Davis, 2013
31
32. Avoid undue influence/coercion:
• Should feel free to decline participation without fear of
repercussion (or disappointing provider)
• Reassure that declining participation will not influence
the care the subject would otherwise receive
• May withdraw from study at any time
• Provide sufficient time for consideration
• Avoid leading or overly reassuring statements
• Just the facts
Important to be aware of any personal objectives!
HOW:
32
33. Primary physician vs. Study physician?
• If PI is also the primary physician:
• Roles may become blurred
• Imbalance of power between patient and doctor
• Patient may feel they don’t want to disappoint
Doctor
• Patient may confuse research with clinical care
• Recruiting a patient is not the same
as recruiting a subject
WHO:
33
34. Documenting the informed consent:
• informed consent shall be documented by the use of a
written consent form approved by the IRB
• signed and dated by the subject or the subject's LAR, at
the time of consent
• A copy shall be given to the person signing the form
21CFR 50.27
TJU OHR Policy IC 701, 4.4:
• The person conducting the consent interview will also
sign and date
• If the PI/CO-I is not present, s/he should sign and date
the consent asap, so that a copy with all signatures can
be given to the subject
HOW:
34
35. Where should consents be stored?
Signed consents:
-Original: study record
-Copies: Subject, eMR
Original, unsigned, IRB approved consents:
-Regulatory binder
CAUTION: copies should be printed on an as
needed basis ONLY!
• One of the most common mistakes is using the
wrong version.
WHERE:
35
36. Documenting the informed consent:
When is it important to include the time with
signature and date?
• If study procedures are due to occur on the same
day of informed consent.
• Demonstrates consent was obtained prior to any
study procedures
HOW:
36
37. Documenting the informed consent
in the Medical Record:
• Identification of study and presenter’s role
• Date and time of discussion
• Individuals present for discussion
• Special circumstances or clarification of
irregularities
• Questions/concerns answered
• Subject verbalized understanding
• Appropriate questions
• Correct “teach-back” responses
HOW:
37
38. Documenting the informed consent
in the Medical Record:
• Ample time given for consideration
• Subject voluntarily agreed to participate
• Consent obtained prior to any study procedures
• Confirmation that a copy of (signed) consent was
provided to subject
• Copy of consent in MR
• Signature of person completing consent process
• Contact information
HOW:
38
39. Best Practices:
• Checklists to ensure systematic, standardized and
thorough process
• Practice/feedback
• Prepare for target audience
Caution!:
• Versions
• Check boxes in the body of consent form
• Missed signatures/dates
HOW:
39
40. “Interventions to improve research
participants' understanding in informed
consent for research: A systematic review”
• Available data suggest that prospective research
participants frequently do not understand
information disclosed to them in the informed
consent process
• Efforts to improve understanding have had limited
success
• Having a study team member or a neutral educator
spend more time talking one-on-one to study
participants appears to be the most effective way
of improving research participants’ understanding
WHY:
Flory, J., and E. Emanuel, 2004. “Interventions to improve research participants' understanding in informed
consent for research: A systematic review,” Journal of the American Medical Association, 292: 1593–1601 40
41. “Factors That Most Inform and Educate
Clinical Research Participants”:
• Study staff and health care professionals play an
essential role in volunteer recruitment and retention
• These individuals are central to establishing trust,
rapport and motivation to comply with participation
requirements
Findings from CISCRP Focus Groups with study volunteers. The Center for Information and Study
on Clinical Research Participation (CISCRP) http://www.ciscrp.org/
WHY:
41
42. Clinical Research Coordinator plays a
critical role:
• Often the primary contact person; “The face of the
Study”
• Serve as a liaison between the PI and the subject
• Primary source of education and understanding of the
study
• Assists subject to navigate study procedures and the
institution
• Subject/patient advocate
WHY:
42
43. Why is it so important?
• Ethical requirement and the LAW!
• Protect the rights, safety and wellbeing
of subjects
• Ensure the subject is fully and accurately
informed
• Comprehend the information
• Decision is voluntary
43
44. Why is it referred to as a process?
• Ongoing interaction between the subject and
research personnel
• Begins with the first contact and exchange of
information
• Continues beyond study termination
Each contact is an opportunity to reiterate
information and ensure that participation
continues to be fully informed and
voluntary
44
45. “Beware of false knowledge; it is
more dangerous than ignorance”
George Bernard Shaw
45
46.
47. References:
Lui, M.B. and Davis, K (2013). A Clinical Trials Manual from the
Duke Clinical Research Institute. Lessons from a Horse Named
Jim, Second Edition. Hoboken, NJ: Wiley-Blackwell.
The Code of Federal Regulations, Title 21-Food and Drugs and
Title 45, Part 46 Protection of Human Subjects.
47
Editor's Notes
Nobel-Prize and Oscar-winning Irish playwright
One of the best ways to get to know your protocol is to be involved with writing the consent.
Not equivalent to complete lack of understanding of the purpose of the study and how research procedures differ from clinical care
PLANNING = SUCCESS! Need adequate TIME!!
Consider safety beyond the time of consent.
Research suggests that low literacy can hamper understanding of a study
See TJU OHR Policies and Procedures for guidance
For translation of the consent form, the investigator may use either: 1) A professional translator; or 2) an individual with special expertise in the particular language required.
Companies providing translation services will provide certification that the translation is an accurate representation of the original English consent form. For individual translators, the investigator must provide the IRB with the name and qualifications of the translator as well as a statement from the translator that the translation is accurate and contains the appropriate cultural nuances. For any study that plans to enroll a non- English-speaking subject, the IRB reserves the right to evaluate the translator’s credentials and, if deemed necessary, require translation of the consent form by another party.
Comfortable setting? Private? Neutral? Family? Adequate time? Patient or Subject?
Consider printing new versions on different colored paper.
**Vulnerable subject/special circumstances requires advanced planning and time!
Consider printing new versions on different colored paper.